E-cigarette, or vaping, product use Associated Lung Injury (EVALI): new scenarios for physicians and radiologists
-
Published:2021-12-03
Issue:
Volume:
Page:
-
ISSN:2532-5264
-
Container-title:Monaldi Archives for Chest Disease
-
language:
-
Short-container-title:Monaldi Arch Chest Dis
Author:
Guarino Carmine,Pedicelli Ilaria,Perna Francesco,Di Spirito Valentina,Fiorentino Giuseppe,Procaccini Fabio,Rea Gaetano
Abstract
A 59-year-old female ex-smoker with 40 pack year smoking history and a 5-year current e-cigarette (EC) use history, presented with progressive dyspnea on exertion and daily cough for 2 months. A CT scan showed a consolidation area with air bronchogram in the middle lobe and non-calcific bilateral nodules, which could be attributed to community-acquired pneumonia. The patient was treated with empiric antibiotics and systemic steroids for 10 days. Infectious, neoplastic and autoimmune pathologies were excluded, whereas a broncho-alveolar lavage revealed an accumulation of lipids in the cytoplasm of the alveolar macrophages. Despite the recommendation of vaping cessation, the patient continued to use EC. A new CT exam, carried out after 18 months, showed reversed halo sign (RHS), patchy ground-glass opacity (GGO), pleuro-parenchymal bands, and indeed perilobular pattern, suggestive of organizing pneumonia (OP). The final diagnosis was E-cigarette, or vaping, product use Associated Lung Injury (EVALI)- related OP.
Publisher
PAGEPress Publications
Subject
Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献